Education

Ph.D. in Immunology, Stanford University School of Medicine, 2012

Current position

Post-doctoral Fellow, National Institute of Child Health and Human Development, National Institutes of Health

Publications

1. Palin, A. C., Ramachandran, V., Acharya, S. and Lewis, D. B. (2013). Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol 190(6): 2682-2691.
   
2. Wilson, S. R., Wilson, J. H., Buonocore, L., Palin, A., Rose, J. K. and Reuter, J. D. (2008). Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity. Comp Med 58(2): 129-139.
   
3. Palin, A., Chattopadhyay, A., Park, S., Delmas, G., Suresh, R., Senina, S., Perlin, D. S. and Rose, J. K. (2007). An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine 25(4): 741-750.
   
4. Ramsburg, E., Publicover, J., Buonocore, L., Poholek, A., Robek, M., Palin, A. and Rose, J. K. (2005). A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. J Virol 79(24): 15043-15053.